CITIUS ONCOLOGY INC (CTOR) Stock Income Statement
NASDAQ:CTOR • US17331Y1091
Current stock price
0.56 USD
-0.02 (-3.45%)
Last:
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.94M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 25.54M | 23.52M | 20.57M | 12.12M | 4.86M | |||
| Research and Development | 6.17M | 6.42M | 4.92M | 4.24M | 3.43M | |||
| Selling, General, and Administrative Expenses | 18.79M | 17.10M | 15.65M | 7.88M | 1.43M | |||
| Operating Income | -22.38M | -23.52M | -20.57M | -12.12M | -4.86M | |||
| Interest Income/Expense | N/A | -181.70K | N/A | N/A | N/A | |||
| Income Before Taxes | -22.58M | -23.70M | -20.57M | -12.12M | -4.86M | |||
| Income Tax | 1.06M | 1.06M | 576.00K | 576.00K | 576.00K | |||
| Net Income | -23.64M | -24.76M | -21.15M | -12.70M | -5.43M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.31 | -0.34 | -0.31 | -0.18 | -0.08 | |||
| Non GAAP EPS | -0.31 | -0.34 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -599.29% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -567.43% | N/A | N/A | N/A | N/A | |||
All data in USD